Enhanced T-cell response to mosquito extracts by NK cells in hypersensitivity to mosquito bites associated with EBV infection and NK cell lymphocytosis

Cancer Science

Volumn 96, Issue 8, 2005, Pages 519-526

  Tokura, Yoshiki ^a   Matsuoka, Hiroyuki ^b   Koga, Chizuko ^a   Asada, Hideo ^c   Seo, Naohiro ^d   Ishihara, Shigehiko ^e   Adachi, Atsuko ^f   Ibe, Masaaki ^g  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Yawata Central Hospital   (Japan)

^f Hyogo Prefectural Kakogawa Hospital   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION YOKOHAMA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 4;

ADOLESCENT; ADULT; AEDES AEGYPTI; AEDES ALBOPICTUS; ANOPHELES; ANOPHELES STEPHENSI; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CULEX PIPIENS; CYTOKINE RELEASE; EPSTEIN BARR VIRUS; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HYPERSENSITIVITY; LYMPHOCYTE CULTURE; LYMPHOCYTOSIS; MALE; MOSQUITO; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SUPPRESSOR CELL; VIRUS INFECTION;

ANIMALS; BITES AND STINGS; CULICIDAE; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTOSIS; T-LYMPHOCYTES; TISSUE EXTRACTS;

EID: 25844490434     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00076.x     Document Type: Article

References (23)

1. Tokura Y, Ishihara S, Tagawa S, Seo S, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 2001; 45: 569-78.
2. Hidano A, Kawakami M, Yago A. Hypersensitivity to mosquito bite and malignant histiocytosis. Jpn J Exp Med 1982; 52: 303-6.
3. Ishihara S, Ohshima K, Tokura Y et al. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res 1997; 88: 82-7.
4. Ishihara S, Yabuta R, Tokura Y, Ohshima K, Tagawa S. Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease. Int J Hematol 2000; 72: 223-8.
5. Tokura Y, Tamura Y, Takigawa M et al. Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol 1990; 126: 362-8.
6. Iwatsuki K, Ohtsuka M, Harada H, Han G, Kaneko F. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 1997; 133: 1081-6.
7. Tokura Y, Ishihara S, Ohshima K et al. Severe mosquito hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption. Br J Dermatol 1998; 138: 905-6.
8. Ruiz-Maldonado R, Parilla FM, de la Luz Orozco-Covarrubias M, Ridaura C, Tamayo Sanchez L, Duran McKinster C. Edematous, scarring vasculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol 1995; 32: 37-44.
9. Adachi A, Horikawa T, Kunisada M et al. Hypersensitivity to mosquito bites in association with chronic Epstein-Barr virus infection and natural killer (NK) leukaemia/lymphoma with expansion of NK cells expressing a low level of CD56. Br J Dermatol 2002; 147: 1036-7.
10. Seo N, Tokura Y, Ishihara S, Takeoka Y, Tagawa S, Takigawa M. Disordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites. Clin Exp Immunol 2000; 120: 413-19.
11. + T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-induced NK cell lymphocytosis. Arch Dermatol 2003; 139: 1601-7.
12. Devergne O, Birkenbach M, Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 1997; 28: 12 041-6.
13. Hanna J, Gonen-Gross T, Fitchett J et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 2004; 114: 1612-23.
14. Maggi E, Mazzetti M, Ravina A et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994; 265: 244-8.
15. + T-cell clones in human immunodeficiency virus infection. Blood 1994; 84: 4262-8.
16. - T helper cells from normal donors and HIV-infected patients. J Immunol 1995; 154: 1408-17.
17. + T cells for IL-4 production. J Exp Med 2004; 199: 1619-30.
18. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5: 337-43.
19. Bream JH, Curiel RE, Yu C-R et al. IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-γ expression in murine NK cells. Blood 2003; 102: 207-14.
20. Noble A, Kemeny DM. Interleukin-4 enhances interferon-γ synthesis but inhibits development of interferon-γ-producing cells. Immunology 1995; 85: 357-63.
21. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997; 100: 1969-79.
22. Osugi Y, Hara J, Tagawa. S et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 4100-3.
23. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001; 166: 5530-9.